News for Connect Biopharma Holdings Limited (CNTB)

**media[639375]**

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to devel

In the first quarter of 2025, Connect Biopharma (CNTB) made significant progress, marked by a successful Type C meeting with the U.S. FDA and the publication of

Initiated Phase 2 Seabreeze STAT Asthma and Seabreeze STAT COPD studies evaluating rademikibart as an adjunct treatment for acute exacerbations in Asthma and CO

Connect Biopharma Holdings (CNTB) posted a net loss of $10.3 million, or $0.19 per share, for the three months ended March 31, 2025, compared with a net loss of $8.

Connect Biopharma (CNTB) Holdings has commenced its Phase 2 Seabreeze STAT COPD study after receiving approval from the U.S. Food and Drug Administration for it

”“ Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026 ”“ SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Li

Connect Biopharma (NASDAQ: CNTB) to present four posters at ATS 2025 International Conference. Focus on rademikibart's efficacy in treating asthma and C

SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited ( CNTB) (Connect Biopharma or the Company), a clinical-stage biopharmaceutica

**media[579900]**

SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited ( CNTB) (”œConnect Biopharma” or the ”œCompany”), a clinical-stage biop

**media[515208]**

Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update

Israel-based thermal energy business Brenmiller Energy Ltd (BNRG) is up over 122 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Document UNITED STATES SECURITIES...

Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update

H.C. Wainwright starts Connect Biopharma stock with buy rating, $7 price target

Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.

Jet.AI Inc. (JTAIZ) is up over 145% in Tuesday's pre-market trading. The following are some of the other stocks making big moves..